Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Active not recruiting × Solid Neoplasms × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 68 Breast Neoplasms 46 Colorectal Neoplasms 40 Neoplasms 38 Neoplasm Metastasis 29 Multiple Myeloma 27 Melanoma 26 Prostatic Neoplasms 24 Pancreatic Neoplasms 24 Stomach Neoplasms 23 Squamous Cell Carcinoma of Head and Neck 23 Recurrence 23 Lung Neoplasms 23 Carcinoma, Renal Cell 23 Lymphoma, Large B-Cell, Diffuse 22 Triple Negative Breast Neoplasms 21 Leukemia, Myeloid, Acute 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Ovarian Neoplasms 20 Lymphoma, Non-Hodgkin 20 Lymphoma, Follicular 19 Leukemia, Lymphocytic, Chronic, B-Cell 18 Glioblastoma 18 Lymphoma 16 Carcinoma, Transitional Cell 16 Uterine Cervical Neoplasms 14 Myelodysplastic Syndromes 14 Lymphoma, Mantle-Cell 13 Leukemia 13 Advanced Solid Tumor 13

Interventions

pembrolizumab 1 Platinum 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04420884 2025-06-13

iintune-1

Takeda

Phase 1/2 Active not recruiting

Solid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡